Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 26, 2017 - Issue 4
Submit an article Journal homepage
596
Views
18
CrossRef citations to date
0
Altmetric
Review

Novel avenues for treating diabetic nephropathy: new investigational drugs

Viviana LacavaUnit of Nephrology and Dialysis, University of Messina, Messina, ItalyView further author information
,
Vincenzo PellicanòUnit of Nephrology and Dialysis, University of Messina, Messina, ItalyView further author information
,
Carmen FerrajoloDepartment of Experimental Medicine, Second University of Naples, Napoli, ItalyView further author information
,
Valeria CernaroUnit of Nephrology and Dialysis, University of Messina, Messina, ItalyView further author information
,
Luca ViscontiUnit of Nephrology and Dialysis, University of Messina, Messina, ItalyView further author information
,
Giovanni ContiUnit of Pediatric Nephrology and Rheumatology, University of Messina, Messina, ItalyView further author information
,
Michele BuemiUnit of Nephrology and Dialysis, University of Messina, Messina, ItalyView further author information
&
Domenico SantoroUnit of Nephrology and Dialysis, University of Messina, Messina, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 445-462 | Received 07 Sep 2016, Accepted 06 Feb 2017, Published online: 17 Feb 2017

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pierre Delanaye & André J. Scheen. (2019) Preventing and treating kidney disease in patients with type 2 diabetes. Expert Opinion on Pharmacotherapy 20:3, pages 277-294.
Read now

Articles from other publishers (17)

Yao Zhou, Qi Wu, Xufang Wang, Wei Li, Qiong Liu & Kun Gao. (2023) Insights Into the Functional Mechanism of Diabetic Kidney Disease Treatment with Sinensetin Based on Network Pharmacology and Molecular Docking. Integrative Medicine in Nephrology and Andrology 10:4.
Crossref
Xi Mao, Ding-qiao Xu, Shi-jun Yue, Rui-jia Fu, Sai Zhang & Yu-ping Tang. (2023) Potential Medicinal Value of Rhein for Diabetic Kidney Disease. Chinese Journal of Integrative Medicine.
Crossref
Lei Peng, Yu Chen, Shaoqing Shi & Heling Wen. (2022) Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management. Stem Cell Research & Therapy 13:1.
Crossref
Junmin Wang, Hongjiao Xiang, Yifei Lu, Tao Wu & Guang Ji. (2021) New progress in drugs treatment of diabetic kidney disease. Biomedicine & Pharmacotherapy 141, pages 111918.
Crossref
Michela Amatruda, Guido Gembillo, Alfio Edoardo Giuffrida, Domenico Santoro & Giovanni Conti. (2021) The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies. Medicina 57:9, pages 868.
Crossref
Ramona Nicotera, Alessandro Casarella, Elisa Longhitano, Davide Bolignano, Michele Andreucci, Giovambattista De Sarro, Valeria Cernaro, Emilio Russo & Giuseppe Coppolino. (2020) Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases. Pharmacological Research 159, pages 105019.
Crossref
Sune Moeller Skov-Jeppesen, Knud Bonnet Yderstraede, Claus Bistrup, Boyle L Jensen, Niels Marcussen, Milad Hanna & Lars Lund. (2020) Low-intensity shockwave therapy in the treatment of diabetic nephropathy: a prospective Phase 1 study. Nephrology Dialysis Transplantation 35:8, pages 1385-1392.
Crossref
Marcus Sondermann, Michał Holecki, Andrea Marita Kirsch, Manuela Bastian, Dagmar-Christiane Fischer & Holger Sven Willenberg. (2020) Diabetes Mellitus and Hypertension—A Case of Sugar and Salt?. International Journal of Molecular Sciences 21:15, pages 5200.
Crossref
Giovanni Conti, Daniela Caccamo, Rossella Siligato, Guido Gembillo, Ersilia Satta, Dario Pazzano, Nicolina Carucci, Antonio Carella, Giuliana Del Campo, Antonino Salvo & Domenico Santoro. (2019) Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy. Medicina 55:10, pages 675.
Crossref
Zi-Jun Yang, Hong-Ru Wang, Yu-Iin Wang, Zi-Han Zhai, Liu-Wei Wang, Liang Li, Cheng Zhang & Lin Tang. (2019) Myricetin Attenuated Diabetes-Associated Kidney Injuries and Dysfunction via Regulating Nuclear Factor (Erythroid Derived 2)-Like 2 and Nuclear Factor-κB Signaling. Frontiers in Pharmacology 10.
Crossref
Ruonan Zhai, Guihua Jian, Teng Chen, Ling Xie, Rui Xue, Chongting Gao, Niansong Wang, Youhua Xu & Dingkun Gui. (2019) Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats. Journal of Diabetes Research 2019, pages 1-14.
Crossref
Sergio Modafferi, Markus Ries, Vittorio Calabrese, Claus. P. Schmitt, Peter Nawroth, Stefan Kopf & Verena Peters. (2019) Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis. Diabetes Therapy 10:1, pages 229-243.
Crossref
Isabel Nguyen, Arianne van Koppen & Jaap A. Joles. 2019. Diabetic Nephropathy. Diabetic Nephropathy 375 413 .
Joanne E. Murphy-Ullrich & Mark J. Suto. (2018) Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease. Matrix Biology 68-69, pages 28-43.
Crossref
Xinyu Li, Yan Wang, Kun Wang & Yonggui Wu. (2018) Renal protective effect of Paeoniflorin by inhibition of JAK2/STAT3 signaling pathway in diabetic mice. BioScience Trends 12:2, pages 168-176.
Crossref
Giuseppe Coppolino, Christian Leporini, Laura Rivoli, Francesco Ursini, Eugenio Donato di Paola, Valeria Cernaro, Franco Arturi, Davide Bolignano, Emilio Russo, Giovambattista De Sarro & Michele Andreucci. (2018) Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials. Pharmacological Research 129, pages 274-294.
Crossref
Anuradha Pandey & Anil Bhanudas Gaikwad. (2017) AT 2 receptor agonist Compound 21: A silver lining for diabetic nephropathy. European Journal of Pharmacology 815, pages 251-257.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.